Payment overview · 2025
General Payments
$38,306.47
14 reported records · 8 companies
Healthcare provider profile · identity verified
Ivan David Rodriguez, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · HIALEAH, FL · NPI 1649292012
Verified facts
What the public records show
CMS Open Payments records show Ivan David Rodriguez, D.O. received $38,306.47 in general payments during 2025 across 14 reported records.
ConvaTec Inc. accounted for 98.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 9 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Nuplazid.
ACADIA Pharmaceuticals Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUPLAZID as an associated drug or biological on 20845 records involving 6448 distinct recipient NPIs. Public Medicare Part D data also shows 58 claims for Nuplazid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ConvaTec Inc. | Unresolved — no canonical attribution shown | $37,800.00 | 98.7% | 1 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $153.97 | 0.4% | 4 | 2025 |
| ViiV Healthcare Company | Unresolved — no canonical attribution shown | $143.75 | 0.4% | 2 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $90.87 | 0.2% | 3 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $39.84 | 0.1% | 1 | 2025 |
| Gilead Sciences, Inc. | Unresolved — no canonical attribution shown | $32.79 | 0.1% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $25.17 | 0.1% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $20.08 | 0.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Debt forgiveness | $37,800.00 | 1 |
| Food and Beverage | $506.47 | 13 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INNOVAMATRIX AC Normalized: innovamatrix ac |
Device | ConvaTec Inc. | $37,800.00 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $153.97 | 4 | 2025 |
Source payment records
|
|||||
| DOVATO Normalized: dovato |
Drug | ViiV Healthcare Company | $119.38 | 1 | 2025 |
Source payment records
|
|||||
| PIFELTRO Normalized: pifeltro |
Drug | Merck Sharp & Dohme LLC | $90.87 | 3 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $39.84 | 1 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $26.36 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25.17 | 1 | 2025 |
Source payment records
|
|||||
| APRETUDE Normalized: apretude |
Drug | ViiV Healthcare Company | $24.37 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $20.08 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| NUPLAZID nuplazid |
2025 | Nuplazid | 2024 | 58 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc Exact reporting entity; no affiliate inference |
2025 | NUPLAZID open payments reported associated product |
CMS Open Payments — General Payments 20845 supporting records · 6448 recipient NPIs · example record 1247763852 |
Nuplazid · 2024 Exact normalized brand match · 1 Part D row |
58 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1088 | 151 |
| Levothyroxine Sodium | Levothyroxine Sodium | 471 | 63 |
| Amlodipine Besylate | Amlodipine Besylate | 447 | 71 |
| Eliquis | Apixaban | 429 | 54 |
| Trazodone Hcl | Trazodone Hcl | 412 | 72 |
| Losartan Potassium | Losartan Potassium | 408 | 63 |
| Metformin Hcl | Metformin Hcl | 371 | 56 |
| Quetiapine Fumarate | Quetiapine Fumarate | 366 | 62 |
| Famotidine | Famotidine | 343 | 64 |
| Gabapentin | Gabapentin | 342 | 51 |
| Lisinopril | Lisinopril | 341 | 49 |
| Mirtazapine | Mirtazapine | 290 | 51 |
| Memantine Hcl | Memantine Hcl | 281 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 272 | 42 |
| Tamsulosin Hcl | Tamsulosin Hcl | 260 | 44 |
| Donepezil Hcl | Donepezil Hcl | 256 | 34 |
| Pantoprazole Sodium | Pantoprazole Sodium | 240 | 61 |
| Levetiracetam | Levetiracetam | 228 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 219 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 204 | 34 |
| Lactulose | Lactulose | 195 | 28 |
| Carvedilol | Carvedilol | 183 | 27 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 175 | 44 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 171 | 33 |
| Furosemide | Furosemide | 165 | 42 |
| Clopidogrel | Clopidogrel Bisulfate | 157 | 33 |
| Divalproex Sodium | Divalproex Sodium | 146 | 24 |
| Latanoprost | Latanoprost | 145 | 25 |
| Baclofen | Baclofen | 133 | 17 |
| Ketoconazole | Ketoconazole | 133 | 48 |
| Finasteride | Finasteride | 124 | 16 |
| Hydrochlorothiazide | Hydrochlorothiazide | 119 | 15 |
| Xarelto | Rivaroxaban | 101 | suppressed |
| Ingrezza | Valbenazine Tosylate | 96 | 15 |
| Mupirocin | Mupirocin | 95 | 57 |
| Omeprazole | Omeprazole | 94 | 24 |
| Sertraline Hcl | Sertraline Hcl | 93 | 21 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 86 | 40 |
| Hydralazine Hcl | Hydralazine Hcl | 86 | 15 |
| Nifedipine Er | Nifedipine | 86 | 16 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 85 | 13 |
| Entresto | Sacubitril/Valsartan | 81 | 12 |
| Benztropine Mesylate | Benztropine Mesylate | 79 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 77 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 76 | 25 |
| Potassium Chloride | Potassium Chloride | 75 | 25 |
| Citalopram Hbr | Citalopram Hydrobromide | 74 | suppressed |
| Trulicity | Dulaglutide | 74 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 69 | 26 |
| Spironolactone | Spironolactone | 69 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 67 | 42 |
| Montelukast Sodium | Montelukast Sodium | 67 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 65 | 12 |
| Azithromycin | Azithromycin | 62 | 43 |
| Ondansetron Hcl | Ondansetron Hcl | 62 | 31 |
| Levofloxacin | Levofloxacin | 61 | 44 |
| Diclofenac Sodium | Diclofenac Sodium | 59 | 16 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 59 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 58 | suppressed |
| Risperidone | Risperidone | 58 | 14 |
| Gemtesa | Vibegron | 56 | suppressed |
| Lamotrigine | Lamotrigine | 56 | suppressed |
| Scopolamine | Scopolamine | 56 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 55 | 20 |
| Ciclopirox | Ciclopirox | 53 | 18 |
| Ezetimibe | Ezetimibe | 53 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 53 | 40 |
| Jardiance | Empagliflozin | 51 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 50 | suppressed |
| Januvia | Sitagliptin Phosphate | 49 | suppressed |
| Prednisone | Prednisone | 48 | 24 |
| Vascepa | Icosapent Ethyl | 47 | suppressed |
| Aripiprazole | Aripiprazole | 46 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 46 | suppressed |
| Atenolol | Atenolol | 45 | suppressed |
| Chlorthalidone | Chlorthalidone | 43 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 42 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 41 | suppressed |
| Pregabalin | Pregabalin | 41 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 39 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 39 | suppressed |
| Nystatin | Nystatin | 38 | 26 |
| Simvastatin | Simvastatin | 38 | suppressed |
| Haloperidol | Haloperidol | 35 | suppressed |
| Ibuprofen | Ibuprofen | 35 | 13 |
| Cephalexin | Cephalexin | 34 | 15 |
| Clonidine Hcl | Clonidine Hcl | 34 | 12 |
| Enalapril Maleate | Enalapril Maleate | 34 | suppressed |
| Olanzapine | Olanzapine | 34 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 33 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 32 | 13 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 32 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 32 | suppressed |
| Tobramycin | Tobramycin | 32 | 23 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 31 | 24 |
| Brimonidine Tartrate | Brimonidine Tartrate | 31 | suppressed |
| Calcitriol | Calcitriol | 31 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 31 | suppressed |
| Insulin Aspart | Insulin Aspart | 31 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 31 | 11 |
| Sucralfate | Sucralfate | 31 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 31 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl/Pf | 30 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 30 | suppressed |
| Hydrocortisone | Hydrocortisone | 29 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 29 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 29 | 12 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 28 | 13 |
| Irbesartan | Irbesartan | 28 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Ozempic | Semaglutide | 28 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 28 | 15 |
| Temazepam | Temazepam | 27 | suppressed |
| Acetylcysteine | Acetylcysteine | 26 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Tradjenta | Linagliptin | 26 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 26 | 13 |
| Methocarbamol | Methocarbamol | 25 | suppressed |
| Multaq | Dronedarone Hcl | 25 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 25 | 14 |
| Bupropion Hcl | Bupropion Hcl | 24 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Metronidazole | Metronidazole | 24 | 16 |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 24 | suppressed |
| Topiramate | Topiramate | 24 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Cyclosporine | Cyclosporine | 23 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 23 | suppressed |
| Lorazepam | Lorazepam | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 22 | suppressed |
| Enbrel | Etanercept | 22 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 22 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 22 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Acamprosate Calcium | Acamprosate Calcium | 21 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 21 | suppressed |
| Levemir | Insulin Detemir | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 20 | suppressed |
| Folic Acid | Folic Acid | 20 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 20 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 20 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Allopurinol | Allopurinol | 19 | suppressed |
| Clonazepam | Clonazepam | 19 | 11 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Sure Comfort | Syringe-Needle,insulin,0.5 Ml | 18 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 17 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Glipizide | Glipizide | 17 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | suppressed |
| Rexulti | Brexpiprazole | 17 | suppressed |
| Amantadine | Amantadine Hcl | 16 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 16 | suppressed |
| Glucagon Emergency Kit | Glucagon | 16 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 16 | suppressed |
| Ssd | Silver Sulfadiazine | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 15 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 15 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Insulin Lispro | Insulin Lispro | 15 | suppressed |
| Nitroglycerin | Nitroglycerin | 15 | suppressed |
| Permethrin | Permethrin | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 14 | suppressed |
| Dexamethasone | Dexamethasone | 14 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 14 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 14 | suppressed |
| Restasis | Cyclosporine | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Tacrolimus | Tacrolimus | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Amiloride Hcl | Amiloride Hcl | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Genvoya | Elviteg/Cob/Emtri/Tenof Alafen | 13 | suppressed |
| Nystop | Nystatin | 13 | suppressed |
| Pentoxifylline | Pentoxifylline | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Sure Comfort | Syringe And Needle,insulin,1ml | 12 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Humalog | Insulin Lispro | 11 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
| Timolol Maleate | Timolol Maleate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $38,306.47 · 14 records | ConvaTec Inc. | APRETUDE, AUSTEDO XR, CAPLYTA, CAPVAXIVE, Cologuard Collection Kit, DOVATO, INNOVAMATRIX AC, NUPLAZID, PIFELTRO | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Nuplazid play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ACADIA Pharmaceuticals Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error